Insiders · VRDN

Seth Harmon

Chief Financial Officer at Viridian Therapeutics, Inc.\DE (VRDN) since September 2023

Seth Harmon has filed 6 insider reports with the SEC since September 2023, as chief Financial Officer at Viridian Therapeutics, Inc.\DE (VRDN). The latest filing, on March 9, 2026, reports shares withheld for taxes or exercise price at Viridian Therapeutics, Inc.\DE (VRDN).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Seth Harmon is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Viridian Therapeutics, Inc.\DE logo
VRDN
Viridian Therapeutics, Inc.\DE
Chief Financial Officersince September 20237,850$30.87Mar 9, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Seth Harmon with

Other insiders at the same companies

Questions about Seth Harmon

What is Seth Harmon's role at Viridian Therapeutics, Inc.\DE?
Seth Harmon reports to the SEC as chief Financial Officer at Viridian Therapeutics, Inc.\DE (VRDN), according to the latest filing on March 9, 2026.
How many shares does Seth Harmon own?
After the latest filing that states it, Seth Harmon directly owned 7,850 shares of Viridian Therapeutics, Inc.\DE (VRDN). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Seth Harmon bought or sold stock recently?
No open-market purchases or sales by Seth Harmon are on file. The filings report shares withheld for taxes or exercise price, grant or award and exercise or conversion of a derivative.
How do I get alerts when Seth Harmon files?
Follow Seth Harmon on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Seth Harmon (SEC CIK 0001993300). Totals count each trade once, skipping amendments whose original is on file, from Sep 19, 2023 on. View on SEC EDGAR